Searchable abstracts of presentations at key conferences in endocrinology

ea0056p735 | Endocrine tumours and neoplasia | ECE2018

Utility of a 3D spheroid cell culture system in neuroendocrine tumors

Herrera-Martinez AD , van Dungen ESR , Dogan F , van Koetsveld1 PM , Castano JP , Feelders RA , Hofland LJ

In vitro 3D cell culture systems seem to appropriately reproduce the tumor cell microenvironment, including nutrients-oxygen conditions and cell-cell interactions. These models may better mimic in vivo tumor conditions and more accurately reproduce drug treatments effects. Since most in vitro studies in neuroendocrine tumors (NETs) are performed in 2D culture systems (monolayer), we aimed to compare the monolayer system with a 3D spheroid cell cultur...

ea0056p759 | Neuroendocrinology | ECE2018

Body composition and bone health in patients treated for craniopharyngioma: a retrospective 10 year follow-up study

van Santen Selvetta S. , Hammarstrand Casper , Olsson Daniel , Wijnen Mark , Johannsson Gudmundur , van der Lely Aart J. , Neggers Sebastian

Introduction: Craniopharyngiomas are benign tumors in the suprasellar region that have encouraging survival rates between 77-93%. Unfortunately, long-term sequelae are frequent, resulting in excessive endocrine and metabolic morbidity, including premature cardiovascular disease and reduced bone health.Objective: To determine the prevalence of unfavorable body composition and low bone mineral density (BMD) in patients with craniopharyngioma.<p class="...

ea0073yi9 | Young Investigator Awards | ECE2021

The value of liquid and solid mixed meal tests to diagnose postprandial reactive hypoglycaemic syndrome

Frederique Van de Velde , Helleputte Simon , Arsène-Hélène Batens , Nieuwenhove Yves Van , Lapauw Bruno

BackgroundPrecise diagnostics for postprandial reactive hypoglycaemic syndrome (PRHS) after gastric bypass surgery (GBS) are lacking. Oral glucose tolerance tests are advocated but might cause early dumping in this population and often cause hypoglycaemic values in a normal population.AimTo evaluate glycaemic responses during liquid and solid mixed meal tolerance tests (LMMTT and SMMTT) in a post-GBS populati...

ea0073aep681 | Thyroid | ECE2021

Thyroid function in adults with Prader-Willi syndrome.

Pellikaan Karlijn , Snijders Fleur , Rosenberg Anna , Sjoerd van den Berg , Aart Jan Van der Lely , De Graaff Laura

IntroductionPrader-Willi syndrome (PWS) is a complex genetic syndrome in which hypothalamic dysfunction leads to hyperphagia and pituitary hormone deficiencies (PHD), among others. The majority of patients have intellectual disability (ID) and use of psychotropic drugs is frequent. Due to hypotonia and the low muscle mass associated with the syndrome, adults with PWS have a low basal metabolic rate (BMR). Combined with hyperphagia, this results in high r...

ea0092op-04-06 | Oral Session 4: Young Investigators / Clinical and Translational | ETA2023

Cardiac function during early treatment for differentiated thyroid carcinoma

Links Mirthe , Lefrandt Joop , Van Der Boom Trynke , Willems Tineke , van der Meer Peter , Links Thera , Zandee Wouter

Background: Differentiated thyroid carcinoma (DTC) survivors have an increased risk of cardiovascular mortality but, the pathophysiological mechanism remains largely unknown. Early treatment for high-risk DTC entails thyroid surgery, radioiodine therapy with thyroid hormone (TH)-withdrawal, and thyroxine suppression therapy (THST). During treatment, patients cycle from severe hypothyroidism to exogenous subclinical hyperthyroidism. TH changes in early DTC treatment might affec...

ea0092op-10-01 | Oral Session 10: Novel diagnostics in Thyroid cancer | ETA2023

Identification of clinical and histopathological risk factors for radioactive iodine refractory disease in patients with follicular and hurthle cell thyroid carcinoma

Stegenga Merel , Oudijk Lindsey , Van Velsen Evert , Medici Marco , Peeters Robin , Edward Visser W. , van Kemenade Folkert

Introduction: Historically, treatment of follicular thyroid carcinoma (FTC) and oncocytic thyroid carcinoma (OTC) is based on thyroidectomy followed by radioiodine (RAI) therapy. Both tumor types have a good prognosis (10-year survival 80-94%), but this changes significantly once RAI-refractory disease occurs (median 3.5 years), which limits further treatment possibilities. The main risk factors for developing RAI-refractory disease in FTC and OTC are unknown. Our aim was to i...

ea0099rc5.1 | Rapid Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

Clinical use of 18F-fluoro-ethyl-tyrosine PET co-registered with MRI for diagnostic dilemmas in prolactinoma

van Trigt Victoria , Bakker Leontine , Lu Ling , Pelsma Iris , Verstegen Marco , van Furth Wouter , Arias-Bouda Lenka Pereira , Biermasz Nienke

Purpose : To assess the utility of (18F)fluoroethyl-L-tyrosine PET co-registered with magnetic resonance imaging (FET-PET/MRICR) in patients with difficult-to-localize prolactinoma to inform clinical decision making and treatment planning.Methods: Retrospective cohort study of 17 consecutive patients with difficult-to-localize prolactinoma undergoing FET-PET/MRICR between October 2020 and Amgust 2022 for either (1) additional inform...

ea0099p176 | Late-Breaking | ECE2024

[18F]FET PET-MRI; A diagnostic tool to improve medical decision-making for small functioning pituitary adenomas in acromegaly patients

van der Groef Romy , Pruis Ilanah , Balvers Rutger , Celine Refardt Julie , Veldhuijzen van Zanten Sophie , Neggers Sebastian

Background: Patients with acromegaly without detectable pituitary adenoma on conventional MRI are often excluded from adenomectomy due to inherent challenges of precise surgical planning, significantly limiting both their therapeutic options and chances of curation. Previous research showed that O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) PET-MRI is an accurate diagnostic tool to detect small functional pituitary adenomas (1). The present study aims to investigate the diagnos...

ea0099p584 | Late-Breaking | ECE2024

Long-term bone health in women with a premenopausal risk-reducing salpingo-oophorectomy (RRSO) compared with women who underwent

Beekman Maarten , Terra Lara , Stuursma Anniek , Heemskerk-Gerritsen Bernadette , van Beurden Marc , van Doorn Lena , van Dorst Eleonora , de Hullu Joanne , Mom Stijn , Roeters van Lennep Jeanine , Gaarenstroom Katja , Korse Tiny , de Keizer Bart , Mitea Cristina , Slart Riemer , Miranda Snoeren , Stokkel Marcel , Verberne Hein , van Asperen Christi , Ausems Margreet , Berger Lieke , de Bock Truuske , Margriet Collee , van Engelen Klaartje , van der Kolk Lizet , Wevers Marijke , Gomez Garcia Encarna , Hooning Maartje , Maas Angela , Mourits Marian , van Leeuwen Flora , Zillikens Carola

Introduction: To prevent ovarian cancer, BRCA1/2 germline pathogenic variant carriers are recommended to undergo premenopausal risk-reducing salpingo-oophorectomy (RRSO). Premenopausal RRSO leads to immediate surgical menopause, which has been associated with an acute phase of rapid bone loss. However, data on long-term effects is scarce and inconclusive. Therefore, we investigated the long-term impact of premenopausal RRSO on bone mineral density (BMD).<p class="...

ea0099ep235 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

A rare cause of glucosuria and aminoaciduria in a patient with well-controlled diabetes mellitus

Inthasot Saohoine , Vanderhulst Julien , Van Daele Sien , Van Hoof Evelien , Kint Cyrielle , Iconaru Laura , de Filette Jeroen

Background: Familial renal glucosuria (FRG) is a rare renal tubular disorder characterized by increased urinary glucose excretion despite normoglycemia. The sodium-glucose cotransporter 2 (SGLT2) is expressed in the proximal renal tubule and is crucial for glucose reabsorption. SLC5A2 is a member of the solute carrier family V transporter genes and encodes for this cotransporter. Mutations in SLC5A2 are the primary cause of FRG.Case pre...